{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T04:56:24Z","timestamp":1767848184256,"version":"3.49.0"},"reference-count":28,"publisher":"Oxford University Press (OUP)","issue":"18","license":[{"start":{"date-parts":[[2019,2,13]],"date-time":"2019-02-13T00:00:00Z","timestamp":1550016000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Martin-Luther-University Halle-Wittenberg","award":["25\/36 (2012)"],"award-info":[{"award-number":["25\/36 (2012)"]}]},{"name":"Martin-Luther-University Halle-Wittenberg","award":["21\/14 (2010)"],"award-info":[{"award-number":["21\/14 (2010)"]}]},{"DOI":"10.13039\/100004807","name":"DFG","doi-asserted-by":"publisher","award":["SFB 1123"],"award-info":[{"award-number":["SFB 1123"]}],"id":[{"id":"10.13039\/100004807","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,9,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Motivation<\/jats:title>\n                  <jats:p>Several gene expression-based risk scores and subtype classifiers for breast cancer were developed to distinguish high- and low-risk patients. Evaluating the performance of these classifiers helps to decide which classifiers should be used in clinical practice for personal therapeutic recommendations. So far, studies that compared multiple classifiers in large independent patient cohorts mostly used microarray measurements. qPCR-based classifiers were not included in the comparison or had to be adapted to the different experimental platforms.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>We used a prospective study of 726 early breast cancer patients from seven certified German breast cancer centers. Patients were treated according to national guidelines and the expressions of 94 selected genes were measured by the mid-throughput qPCR platform Fluidigm. Clinical and pathological data including outcome over five years is available. Using these data, we could compare the performance of six classifiers (scmgene and research versions of PAM50, ROR-S, recurrence score, EndoPredict and GGI). Similar to other studies, we found a similar or even higher concordance between most of the classifiers and most were also able to differentiate high- and low-risk patients. The classifiers that were originally developed for microarray data still performed similarly using the Fluidigm data. Therefore, Fluidigm can be used to measure the gene expressions needed by several classifiers for a large cohort with little effort. In addition, we provide an interactive report of the results, which enables a transparent, in-depth comparison of classifiers and their prediction of individual patients.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Availability and implementation<\/jats:title>\n                  <jats:p>https:\/\/services.bio.ifi.lmu.de\/pia\/.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Supplementary information<\/jats:title>\n                  <jats:p>Supplementary data are available at Bioinformatics online.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/bioinformatics\/btz103","type":"journal-article","created":{"date-parts":[[2019,2,13]],"date-time":"2019-02-13T21:18:27Z","timestamp":1550092707000},"page":"3412-3420","source":"Crossref","is-referenced-by-count":7,"title":["Comparison of six breast cancer classifiers using qPCR"],"prefix":"10.1093","volume":"35","author":[{"given":"Evi","family":"Berchtold","sequence":"first","affiliation":[{"name":"Department of Informatics, Institute of Bioinformatics, Ludwig-Maximilians-Universit\u00e4t M\u00fcnchen , M\u00fcnchen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martina","family":"Vetter","sequence":"additional","affiliation":[{"name":"Department of Gynecology, Institute of Clinical Epidemiology, Martin-Luther-Universit\u00e4t , Halle an der Saale, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melanie","family":"G\u00fcndert","sequence":"additional","affiliation":[{"name":"Physiology Weihenstephan, Technical University of Munich, Freising , Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gergely","family":"Csaba","sequence":"additional","affiliation":[{"name":"Department of Informatics, Institute of Bioinformatics, Ludwig-Maximilians-Universit\u00e4t M\u00fcnchen , M\u00fcnchen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Fathke","sequence":"additional","affiliation":[{"name":"Department of Gynecology, Institute of Clinical Epidemiology, Martin-Luther-Universit\u00e4t , Halle an der Saale, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanne E","family":"Ulbrich","sequence":"additional","affiliation":[{"name":"Physiology Weihenstephan, Technical University of Munich, Freising , Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Thomssen","sequence":"additional","affiliation":[{"name":"Department of Gynecology, Institute of Clinical Epidemiology, Martin-Luther-Universit\u00e4t , Halle an der Saale, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralf","family":"Zimmer","sequence":"additional","affiliation":[{"name":"Department of Informatics, Institute of Bioinformatics, Ludwig-Maximilians-Universit\u00e4t M\u00fcnchen , M\u00fcnchen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva J","family":"Kantelhardt","sequence":"additional","affiliation":[{"name":"Department of Gynecology, Institute of Clinical Epidemiology, Martin-Luther-Universit\u00e4t , Halle an der Saale, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2019,2,13]]},"reference":[{"key":"2023013108045584800_btz103-B1","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1200\/JCO.2008.18.1370","article-title":"Supervised risk predictor of breast cancer based on intrinsic subtypes","volume":"27","author":"Bernard","year":"2009","journal-title":"J. Clin. Oncol"},{"key":"2023013108045584800_btz103-B2","doi-asserted-by":"crossref","first-page":"djw149.","DOI":"10.1093\/jnci\/djw149","article-title":"Comparison of EndoPredict and EPclin with oncotype DX recurrence score for prediction of risk of distant recurrence after endocrine therapy","volume":"108","author":"Buus","year":"2016","journal-title":"J. Natl. Cancer Inst"},{"key":"2023013108045584800_btz103-B3","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1056\/NEJMoa1602253","article-title":"70-Gene signature as an aid to treatment decisions in early-stage breast cancer","volume":"375","author":"Cardoso","year":"2016","journal-title":"N. Engl. J. Med"},{"key":"2023013108045584800_btz103-B4","first-page":"2929","article-title":"Breast cancer intrinsic subtype classification, clinical use and future trends","volume":"5","author":"Dai","year":"2015","journal-title":"Am. J. Cancer Res"},{"key":"2023013108045584800_btz103-B5","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1056\/NEJMoa052933","article-title":"Concordance among gene-expression-based predictors for breast cancer","volume":"355","author":"Fan","year":"2006","journal-title":"N. Engl. J. Med"},{"key":"2023013108045584800_btz103-B6","doi-asserted-by":"crossref","first-page":"6012","DOI":"10.1158\/1078-0432.CCR-11-0926","article-title":"A new molecular predictor of distant recurrence in ER-positive, HER2-negative breast cancer adds independent information to conventional clinical risk factors","volume":"17","author":"Filipits","year":"2011","journal-title":"Clin. Cancer Res"},{"key":"2023013108045584800_btz103-B7","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1093\/bioinformatics\/btv693","article-title":"Genefu: an R\/Bioconductor package for computation of gene expression-based signatures in breast cancer","volume":"32","author":"Gendoo","year":"2016","journal-title":"Bioinformatics"},{"key":"2023013108045584800_btz103-B8","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1093\/annonc\/mdt303","article-title":"Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013","volume":"24","author":"Goldhirsch","year":"2013","journal-title":"Ann. Oncol"},{"key":"2023013108045584800_btz103-B9","doi-asserted-by":"crossref","first-page":"394.","DOI":"10.1186\/1471-2164-9-394","article-title":"Comparison of prognostic gene expression signatures for breast cancer","volume":"9","author":"Haibe-Kains","year":"2008","journal-title":"BMC Genomics"},{"key":"2023013108045584800_btz103-B10","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1093\/jnci\/djr545","article-title":"A three-gene model to robustly identify breast cancer molecular subtypes","volume":"104","author":"Haibe-Kains","year":"2012","journal-title":"J. Natl. Cancer Inst"},{"key":"2023013108045584800_btz103-B11","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1200\/JCO.2006.10.3523","article-title":"Proposal for standardized definitions for efficacy end points in adjuvant breast cancer trials: the STEEP system","volume":"25","author":"Hudis","year":"2007","journal-title":"J. Clin. Oncol"},{"key":"2023013108045584800_btz103-B12","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1634\/theoncologist.2012-0007","article-title":"Agreement in risk prediction between the 21-gene recurrence score assay and the PAM50 breast cancer intrinsic classifier in early-stage estrogen receptor-positive breast cancer","volume":"17","author":"Kelly","year":"2012","journal-title":"Oncologist"},{"key":"2023013108045584800_btz103-B13","doi-asserted-by":"crossref","first-page":"7512","DOI":"10.1158\/1078-0432.CCR-17-1535","article-title":"Gene expression signatures and immunohistochemical subtypes add prognostic value to each other in breast cancer cohorts","volume":"23","author":"Lundberg","year":"2017","journal-title":"Clin. Cancer Res"},{"key":"2023013108045584800_btz103-B14","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s10549-016-3725-z","article-title":"Prognostic ability of EndoPredict compared to research-based versions of the PAM50 risk of recurrence (ROR) scores in node-positive, estrogen receptor-positive, and HER2-negative breast cancer. A GEICAM\/9906 sub-study","volume":"156","author":"Martin","year":"2016","journal-title":"Breast Cancer Res. Treat"},{"key":"2023013108045584800_btz103-B15","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1056\/NEJMoa041588","article-title":"A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer","volume":"351","author":"Paik","year":"2004","journal-title":"N. Engl. J. Med"},{"key":"2023013108045584800_btz103-B16","doi-asserted-by":"crossref","first-page":"e0183452.","DOI":"10.1371\/journal.pone.0183452","article-title":"Comparison of risk classification between EndoPredict and MammaPrint in ER-positive\/HER2-negative primary invasive breast cancer","volume":"12","author":"Pelaez-Garcia","year":"2017","journal-title":"PLoS One"},{"key":"2023013108045584800_btz103-B17","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.1093\/annonc\/mds080","article-title":"Concordance among gene expression-based predictors for ER-positive breast cancer treated with adjuvant tamoxifen","volume":"23","author":"Prat","year":"2012","journal-title":"Ann. Oncol"},{"key":"2023013108045584800_btz103-B18","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s10549-012-2143-0","article-title":"PAM50 assay and the three-gene model for identifying the major and clinically relevant molecular subtypes of breast cancer","volume":"135","author":"Prat","year":"2012","journal-title":"Breast Cancer Res. Treat"},{"key":"2023013108045584800_btz103-B19","volume-title":"R: A Language and Environment for Statistical Computing","year":"2016"},{"key":"2023013108045584800_btz103-B20","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1001\/jamaoncol.2017.5524","article-title":"Comparison of the performance of 6 prognostic signatures for estrogen receptor-positive breast cancer a secondary analysis of a randomized clinical trial","volume":"4","author":"Sestak","year":"2018","journal-title":"JAMA Oncol"},{"key":"2023013108045584800_btz103-B21","volume-title":"TNM Classification of Malignant Tumours","author":"Sobin","year":"2011"},{"key":"2023013108045584800_btz103-B22","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1056\/NEJMoa1510764","article-title":"Prospective validation of a 21-gene expression assay in breast cancer","volume":"373","author":"Sparano","year":"2015","journal-title":"N. Engl. J. Med"},{"key":"2023013108045584800_btz103-B23","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa1804710","article-title":"Adjuvant chemotherapy guided by a 21-gene expression assay in breast cancer","volume":"379","author":"Sparano","year":"2018","journal-title":"N. Engl. J. Med"},{"key":"2023013108045584800_btz103-B24","doi-asserted-by":"crossref","first-page":"e1662.","DOI":"10.1371\/journal.pone.0001662","article-title":"High throughput gene expression measurement with real time PCR in a microfluidic dynamic array","volume":"3","author":"Spurgeon","year":"2008","journal-title":"PLoS One"},{"key":"2023013108045584800_btz103-B25","doi-asserted-by":"crossref","first-page":"424.","DOI":"10.1186\/1471-2164-10-424","article-title":"Improvement of the clinical applicability of the Genomic Grade Index through a qRT-PCR test performed on frozen and formalin-fixed paraffin-embedded tissues","volume":"10","author":"Toussaint","year":"2009","journal-title":"BMC Genomics"},{"key":"2023013108045584800_btz103-B26","doi-asserted-by":"crossref","first-page":"e58483.","DOI":"10.1371\/journal.pone.0058483","article-title":"Comparison of EndoPredict and Oncotype DX test results in hormone receptor positive invasive breast cancer","volume":"8","author":"Varga","year":"2013","journal-title":"PLoS One"},{"key":"2023013108045584800_btz103-B27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1002240","article-title":"Most random gene expression signatures are significantly associated with breast cancer outcome","volume":"7","author":"Venet","year":"2011","journal-title":"PLoS Comput. Biol"},{"key":"2023013108045584800_btz103-B28","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1200\/JCO.2011.38.8595","article-title":"Definition and impact of pathologic complete response on prognosis after neoadjuvant chemotherapy in various intrinsic breast cancer subtypes","volume":"30","author":"Von Minckwitz","year":"2012","journal-title":"J. Clin. Oncol"}],"container-title":["Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/bioinformatics\/article-pdf\/35\/18\/3412\/48975110\/bioinformatics_35_18_3412.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bioinformatics\/article-pdf\/35\/18\/3412\/48975110\/bioinformatics_35_18_3412.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,31]],"date-time":"2023-01-31T13:33:31Z","timestamp":1675172011000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bioinformatics\/article\/35\/18\/3412\/5317163"}},"subtitle":[],"editor":[{"given":"Russell","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2019,2,13]]},"references-count":28,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2019,9,15]]}},"URL":"https:\/\/doi.org\/10.1093\/bioinformatics\/btz103","relation":{},"ISSN":["1367-4803","1367-4811"],"issn-type":[{"value":"1367-4803","type":"print"},{"value":"1367-4811","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,9,15]]},"published":{"date-parts":[[2019,2,13]]}}}